Medicines Co. (MDCO) Tops Q3 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income from operations: -75.74M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Income from operations: -75.74M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of $0.18, $0.30 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $172.4 million versus the consensus estimate of $188.3 million.
Adjusted net income was $29.3 million, or $0.47 per share, for the third quarter 2013.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
- Seagate Technology shares rise after recent selloff
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
